DDI-DrugBank.d577.s0 >> In elderly patients concurrently receiving certain diuretics, primarily thiazides, an increased incidence of thrombopenia with purpura has been reported. >> 51-59,72-80
DDI-DrugBank.d577.s1 >> It has been reported that sulfamethoxazole may prolong the prothrombin time in patients who are receiving the anticoagulant warfarin. >> 26-41,110-122,124-131
DDI-DrugBank.d577.s2 >> This interaction should be kept in mind when Gantanol is given to patients already on anticoagulant therapy, and the coagulation time should be reassessed. >> 45-52
DDI-DrugBank.d577.s3 >> Sulfamethoxazole may inhibit the hepatic metabolism of phenytoin. >> 0-15,55-63
DDI-DrugBank.d577.s4 >> At a 1.6-g dose, sulfamethoxazole produced a slight but significant increase in the half-life of phenytoin but did not produce a corresponding decrease in the metabolic clearance rate. >> 17-32,97-105
DDI-DrugBank.d577.s5 >> When administering these drugs concurrently, one should be alert for possible excessive phenytoin effect. >> 88-96
DDI-DrugBank.d577.s6 >> Sulfonamides can also displace methotrexate from plasma protein-binding sites, thus increasing free methotrexate concentrations. >> 0-11,31-42,100-111
DDI-DrugBank.d577.s7 >> The presence of sulfamethoxazole may interfere with the Jaff    alkaline picrate reaction assay for creatinine, resulting in overestimations of about 10% in the range of normal values. >> 16-31
